Live Quote · NASDAQOCULHealthcare· Biotechnology

Ocular Therapeutix, Inc.

$5.57▼ 4.95%($-0.29)
MKT CAP $1.23BNEXT EARNINGS Feb 4, 2027
50%
Bullish
TickerSpark Score
41/100
▌ Weak
40
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCUL research report →

Analyst Price Target
$23.00+312.9% vs. today

Range $14 – $30

Analyst RatingBuy
17 Buy2 Hold0 Sell

Price Chart

-52.47% · this period
$16.11$10.84$5.57Nov 20May 26Nov 20
52-Week Range0% of range
Low
$5.54
Current
$5.57
High
$16.44